TABLE 3.
Performance of Aptima SARS-CoV-2 TMA and Panther Fusion SARS-CoV-2 RT-PCR assays for detection of commercially available SARS-CoV-2 controlsa
| SARS-CoV-2 control vendor | Panther Fusion SARS-CoV-2 RT-PCR result |
||
|---|---|---|---|
| Concn (c/ml) | Aptima SARS-CoV-2/TMA (n/N) (%) | Panther Fusion SARS-CoV-2 RT-PCR (n/N) (%) | |
| Exact Diagnostics SARS-CoV-2 standard | 833 | 40/40 (100) | 38/38 (100) |
| 417 | 40/40 (100) | 39/39 (100) | |
| 194 | 40/40 (100) | 40/40 (100) | |
| 83 | 40/40 (100) | 40/40 (100) | |
| 19 | 35/39 (90) | 30/40 (75) | |
| 8 | 29/39 (74) | 21/40 (53) | |
| SeraCare Accuplex SARS-CoV-2 verification panel | 833 | 20/20 (100) | 20/20 (100) |
| 417 | 19/19 (100) | 20/20 (100) | |
| 194 | 19/19 (100) | 20/20 (100) | |
| 83 | 20/20 (100) | 18/20 (90) | |
| 19 | 16/40 (40) | 11/40 (28) | |
| 8 | 7/40 (18) | 4/40 (10) | |
| ZeptoMetrics SARS-CoV-2 (recombinant) | 833 | 39/39 (100) | 40/40 (100) |
| 417 | 40/40 (100) | 40/40 (100) | |
| 194 | 37/37 (100) | 40/40 (100) | |
| 83 | 39/40 (97.5) | 32/40 (80) | |
| 19 | 12/40 (30) | 14/40 (35) | |
| 8 | 12/40 (30) | 8/40 (20) | |
a
The lowest concentration of each panel with 100% positivity is shown in bold type. n/N, number positive/number tested.